Prudential Financial’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$168K Buy
+15,430
New +$193K ﹤0.01% 2168
2025
Q4
Sell
-12,155
Closed -$157K 2366
2025
Q3
$157K Buy
12,155
+35
+0.3% +$468 ﹤0.01% 2242
2025
Q2
$216K Buy
+12,120
New +$211K ﹤0.01% 2185
2025
Q1
Sell
-7,170
Closed -$214K 2353
2024
Q4
$214K Buy
+7,170
New +$152K ﹤0.01% 2076
2022
Q1
Sell
-1,998
Closed -$214K 2667
2021
Q4
$214K Sell
1,998
-201
-9% -$20.2K ﹤0.01% 2526
2021
Q3
$288K Sell
2,199
-49
-2% -$7.41K ﹤0.01% 2341
2021
Q2
$498K Sell
2,248
-30
-1% -$5.84K ﹤0.01% 2140
2021
Q1
$301K Hold
2,278
﹤0.01% 2271
2020
Q4
$395K Sell
2,278
-34
-1% -$4.65K ﹤0.01% 2158
2020
Q3
$257K Buy
+2,312
New +$185K ﹤0.01% 2218
2020
Q2
Sell
-38,537
Closed -$2.6M 2448
2020
Q1
$2.6M Buy
38,537
+30,326
+369% +$2.4M 0.01% 1240
2019
Q4
$692K Sell
8,211
-309
-4% -$24.9K ﹤0.01% 1974
2019
Q3
$637K Sell
8,520
-66,743
-89% -$5.34M ﹤0.01% 1984
2019
Q2
$4.76M Buy
75,263
+67,873
+918% +$3.44M 0.01% 1182
2019
Q1
$356K Buy
+7,390
New +$356K ﹤0.01% 2175
2018
Q4
Sell
-7,430
Closed -$389K 2427
2018
Q3
$389K Buy
7,430
+840
+13% +$33.4K ﹤0.01% 2114
2018
Q2
$206K Buy
+6,590
New +$183K ﹤0.01% 2338

Other funds holding NVCR

Prudential Financial's NVCR Position: Q1 2026 in Review

Prudential Financial opened a new position in NovoCure (NVCR) in Q1 2026: 15,430 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #2168 among its holdings. This is a return to the name: Prudential Financial previously reported a position in NVCR as recently as Q3 2025.

Prudential Financial first reported a position in NVCR in Q2 2018 and has held it in 17 quarters since. The position peaked at $4.76M in Q2 2019. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Prudential Financial held 15,430 shares of NovoCure worth $168K as of Q1 2026.
  • NovoCure was a new Prudential Financial position in Q1 2026.
  • NovoCure made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2168 holding.
  • Prudential Financial first reported a position in NovoCure in Q2 2018 and has held it in 17 quarters since.
  • Prudential Financial's NovoCure position peaked at $4.76M in Q2 2019.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.